Using minibeam radiation to improve delivery of cancer-fighting nanoparticles to pancreatic tumors
Official title: Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
Funded at Univ of North Carolina Chapel Hill · NIH-11054612 · Data updated 2026-11-12
This study is exploring a new way to help deliver tiny cancer-fighting particles directly to pancreatic tumors using a special type of radiation therapy, which could make treatments more effective and safer for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | April 1, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $555,851 |
| NIH project number | 5R01CA247652-05 |
| Project ID | NIH-11054612 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with pancreatic cancer who may benefit from advanced treatment options.
✕Less likely to help
Patients with cancers other than pancreatic cancer or those who are not eligible for nanoparticle therapies may not receive benefit from this research.
What this research studies
This research investigates a novel approach to enhance the delivery of nanoparticle anticancer agents specifically to pancreatic cancer tumors. By utilizing minibeam radiation therapy (MRT), which has unique characteristics compared to traditional radiation methods, the study aims to improve the uptake of these nanoparticles in solid tumors. The researchers believe that MRT can modify tumor blood vessels and increase blood flow, thereby allowing more nanoparticles to reach the tumor site effectively. This innovative method could potentially lead to more effective and safer cancer treatments for patients with pancreatic cancer.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for patients with pancreatic cancer by enhancing the effectiveness of nanoparticle-based therapies.
How similar studies have gone: Previous studies have shown promise in using innovative radiation therapies to enhance drug delivery, suggesting that this approach may yield successful outcomes.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Zamboni, William C — Univ of North Carolina Chapel Hill
- Study coordinator: Zamboni, William C
Related research
Other NIH-funded projects on the same topics.
-
Targeting tumor survival signals to improve radiation response in pancreatic cancer
This grant tests a new approach to make pancreatic cancer tumors more sensitive to radiation, aiming to help patients with locally advanced disease become eligible for surgery or experience better disease control.
-
Investigating the immune effects of carbon ion radiation therapy for pancreatic cancer
This study is looking at how a special type of radiation therapy called carbon ion radiation therapy might help boost the immune system to fight pancreatic cancer better than regular X-ray therapy, and it's being tested in mice to see if it could lead to new treatment options for patients like you.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.